ABSTRACT
BACKGROUND: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) infection elicits inflammatory manifestations that relate with a "cytokine storm." OBJECTIVE: The aim of this research was to assess the role of circulating interleukin 6 (IL-6) levels and other inflammatory markers in patients with coronavirus disease 2019 (COVID-19) on metabolic functions and accompanying clinical complications. Patients and Methods. A total of 165 patients diagnosed with COVID-19 pneumonia were examined for medical features and inflammatory markers such as blood IL-6, CRP, ferritin, LDH, neutrophil/lymphocyte index (NLI), D-Dimer, and Red Cell Distribution Width (RDW). Regression analyses concerning electronically collected medical data were adjusted by appropriate factors and confounding variables. Results. Plasma IL-6 determinations evidenced a consistent association with hospital stay days, Intensive Care Unit (ICU) admission, and mortality rates. Similar trends were found for other proinflammatory variables, where ferritin and NLI showed a remarkable value as surrogates. Hyperglycaemia and the Charlson Comorbidity Index Score were positively associated with the inflammatory response induced by the SARS-COV-2 infection. An unhealthy lifestyle such as smoking and alcoholic drinks consumption as well as excessive body adiposity influenced inflammatory-related outcomes in the screened patients. CONCLUSION: IL-6 together with other inflammatory biomarkers accompanied poor clinical and metabolic outcomes in COVID-19-infected patients. IL-6 may result in a suitable proxy to individually categorise patients in order to manage this infectious pandemic.
Subject(s)
COVID-19/complications , Inflammation/etiology , Interleukin-6/blood , SARS-CoV-2 , Aged , C-Reactive Protein/analysis , COVID-19/immunology , COVID-19/metabolism , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Retrospective StudiesABSTRACT
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disease. To date, many reviews and series have been described. We report the experience of our center by presenting a review of 56 PNH patient cases with an average age at diagnosis of 38 yr and follow-ups beginning at approximately 40 yr; the median survival rate was 11 yr. The average clonal size upon diagnosis was 48%, presenting a variable evolution. Thrombotic episodes and cancer were five each, and the main causes of death among our patients were equal at 8.9%. Radiological study by magnetic resonance imaging is presented as a fundamental technique for estimating the deposit of iron levels in the liver and kidney, as well as in some decisive cases at the start of eculizumab therapy. Sixteen patients have been treated with eculizumab so far in our series, and being a safe drug, it provides improvement in the patients' quality of life, and the disappearance of clinical symptoms, and avoids the emergence of new thrombosis.
Subject(s)
Hemoglobinuria, Paroxysmal/diagnosis , Hemoglobinuria, Paroxysmal/therapy , Adolescent , Adult , Aged , Aged, 80 and over , Antibodies, Monoclonal, Humanized/therapeutic use , Bone Marrow/pathology , Female , Follow-Up Studies , Hematopoietic Stem Cell Transplantation , Hemoglobinuria, Paroxysmal/complications , Hemoglobinuria, Paroxysmal/mortality , Humans , Immunophenotyping , Liver Transplantation , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasms/etiology , Pregnancy , Renal Insufficiency/etiology , Retrospective Studies , Transplantation, Homologous , Treatment Outcome , Young AdultABSTRACT
PURPOSE: To describe the contrast-enhanced ultrasound (CEUS) features of liver and biliary lesions related to hepatic artery thrombosis in adult patients with orthotopic liver transplantation. METHODS: Gray-scale ultrasound (US), Doppler US, and CEUS using a hexafluoride-based US contrast media were performed on a series of eight patients with liver transplantation and hepatic artery thrombosis. RESULTS: Six of the cases presented infarctions, seen as parenchymal geographic areas of lack of enhancement. Biliary necrosis, seen as nonenhancing periportal cuff, was seen in one case. Infected biloma, seen as a nonenhancing hilar collection, was present in two cases. Infarction and biloma coexisted in one patient. Two abscesses were seen as a late complication in one case. One of them was seen as a typical necrotic abscess with a central nonenhancing area and peripheral rim enhancement higher than the surrounding liver. The other one was seen as a partially liquefied abscess. CONCLUSION: CEUS was useful to diagnose lesions related to hepatic artery thrombosis in liver transplantation. It enabled distinguishing between them and to define their size and extension better than conventional gray-scale US.
Subject(s)
Contrast Media , Liver Diseases/diagnostic imaging , Liver Transplantation , Thrombosis/diagnostic imaging , Abscess/diagnostic imaging , Adult , Female , Hepatic Artery/diagnostic imaging , Humans , Image Enhancement/methods , Image Processing, Computer-Assisted/methods , Infarction/diagnostic imaging , Liver/diagnostic imaging , Male , Middle Aged , Necrosis/diagnostic imaging , Postoperative Complications/diagnostic imaging , Retrospective Studies , Ultrasonography, Doppler, Color/methodsABSTRACT
Persistent hepatitis C virus (HCV) infection is associated with progressive hepatic fibrosis and ultimately hepatocellular carcinoma. The interleukin-28B (IL28B) rs12979860 polymorphism is associated with fibrosis progression in chronic HCV infection. IL28B encodes interferon-λ, which has both antiviral and anti-proliferative properties. This study aimed to determine whether IL28B rs12979860 polymorphism is also associated with development of hepatocellular carcinoma both in chronic HCV infection and in non-viral-related cirrhosis. Real-time polymerase chain reaction and melting curve analyses were used to genotype 311 patients who underwent liver transplantation for HCV cirrhosis (n = 202) or alcoholic cirrhosis (n = 109). HCV patients were older (p = 0.012) and less likely males (p < 0.001) than patients with alcoholic cirrhosis. IL28B rs12979860 TT genotype [OR 6.08, 95 % CI 2.11-17.53; p < 0.001] and T allele carriage (CT + TT; OR 2.3, CI 95 % 1.42-3.72; p = 0.001) were more frequent among HCV patients and, among them, more common in patients infected with HCV genotype 1 (CT + TT; OR 1.79, CI 95 % 1.03-3.09; p = 0.009). Incidence of hepatocellular carcinoma was higher in HCV cirrhosis (OR 2.7, CI 95 % 1.5-4.7; p < 0.001), with no differences according to HCV genotype. IL28B genotype distribution was similar among patients with or without hepatocellular carcinoma, in both HCV patients regardless viral genotype (p = 0.84) and alcoholic patients (p = 0.91). Multivariate analysis showed that older age (OR 1.06, CI 95 % 1.02-1.1; p = 0.003) and male gender (OR 2.49, CI 95 % 1.24-5; p = 0.01) were independent risk factors for hepatocellular carcinoma in HCV patients. In summary, the current study did not find a significant association between IL28B rs12979860 polymorphism and hepatocarcinogenesis.
Subject(s)
Carcinoma, Hepatocellular/genetics , Genetic Predisposition to Disease , Interleukins/genetics , Liver Cirrhosis/genetics , Liver Neoplasms/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/epidemiology , Female , Gene Frequency , Genotype , Genotyping Techniques , Hepatitis C, Chronic/complications , Humans , Interferons , Liver Cirrhosis/complications , Liver Cirrhosis/epidemiology , Liver Neoplasms/epidemiology , Male , Middle Aged , Polymorphism, Single Nucleotide , Retrospective Studies , Young AdultABSTRACT
BACKGROUND: Polymorphisms of the IL28B gene (encoding interferon-λ3) determine the spontaneous course of hepatitis C virus (HCV) infection and its response to antiviral therapy. We investigated the influence of the IL28B rs12979860 (C>T) polymorphism on the risk of severe HCV recurrence after liver transplantation. METHODS: Ninety patients who underwent transplantation because of HCV cirrhosis were retrospectively analyzed; forty-one (45.6%) of them with severe HCV recurrence. Forty-eight of their paired donors were available and were also analyzed. IL28B rs12979860 was genotyped by real-time polymerase chain reaction, and evaluated for association with severe HCV recurrence, along with other variables, by univariate and multivariate analyses. RESULTS: The risk allele rs12979860-T was more common in transplanted patients (66.7%) than reported in healthy whites, and it was significantly overrepresented among patients with severe HCV recurrence, in comparison with patients without it (82.9% vs. 53.1%, odds ratio [OR]=4.30, etiologic fraction=63.6%; P=0.0028). Furthermore, separate analysis of the recipients' genotypes indicated that the risk of severe HCV recurrence increased with the dose of the T allele (linear trend, P=0.0068). Multiple logistic regression analysis confirmed the contribution of the IL28B genotype to the risk of severe HCV recurrence (OR=4.27; P=0.014), independently of other associated factors. Allele IL28B T in the donor seemed to have an opposite effect than that in the recipient (OR=0.46), but the study was underpowered to demonstrate this unforeseen effect (P=0.1995). CONCLUSIONS: The recipient IL28B rs12979860 genotype has a major influence on the posttransplantation course of HCV infection, being a valuable biomarker for patient care in liver transplantation.
Subject(s)
Hepacivirus/metabolism , Hepatitis C/diagnosis , Interleukins/genetics , Liver Failure/therapy , Liver Transplantation/methods , Adult , Aged , Alleles , Female , Genotype , Hepatitis C/complications , Humans , Interferons , Liver Failure/complications , Liver Failure/genetics , Liver Transplantation/adverse effects , Male , Middle Aged , Multivariate Analysis , Polymorphism, Genetic , Real-Time Polymerase Chain Reaction/methods , RecurrenceABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Clostridioides difficile , Clostridioides difficile/isolation & purification , Diarrhea/complications , Diarrhea/therapy , Liver Transplantation , Ganciclovir , Metronidazole/therapeutic use , Coliforms/methods , Enterocolitis, Pseudomembranous/complications , Enterocolitis, Pseudomembranous/drug therapy , Clostridioides difficile/cytology , Diarrhea/microbiology , Diarrhea/physiopathology , Immunosuppressive Agents/therapeutic use , Hypercholesterolemia/complications , Heart Diseases/complications , Enzyme-Linked Immunosorbent Assay , Vancomycin/therapeutic use , Heart Failure/complicationsABSTRACT
No disponible